Benefit on biochemical control of adjuvant radiation therapy in patients with pathologically involved seminal vesicles after radical prostatectomy

Tumori

Volumn 93, Issue 5, 2007, Pages 445-451

  Greco, Carlo ^a,b   Castiglioni, Simona ^b   Fodor, Andrei ^b   De Cobelli, Ottavio ^b   Longaretti, Nadia ^b   Rocco, Bernardo ^b   Vavassori, Andrea ^b   Orecchia, Roberto ^b,c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Biochemical failure; Conformal radiotherapy; Prostatectomy; Seminal vesicle invasion

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATECTOMY; RADIATION; RADIATION DOSE; SEMINAL VESICLE; UNIVARIATE ANALYSIS;

EID: 36749082103     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160709300507     Document Type: Article

References (49)

1. Epstein JI, Carmichael M, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol, 149: 1040-1045, 1993.
2. Epstein JI, Partin AW, Potter SR, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology, 56: 283-288, 2000.
3. Mukamel E, deKernion JB, Hannah J, Smith RB, Skinner DG, Goodwin WE: The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. Cancer, 59: 1535-1538, 1987.
4. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM: The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol, 17: 1252-1261, 1993.
5. Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA: Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol, 143: 1183-1187, 1990.
6. Bolla M, van PH, Collette L, van CP, Vekemans K, Da PL, de Reijke TM, Verbaeys A, Bosset JF, van VR, Marechal JM, Scalliet P, Haustermans K, Pierart M: Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet, 366: 572-578, 2005.
7. Mayer R, Pummer K, Quehenberger F, Mayer E, Fink L, Hackl A: Postprostatectomy radiotherapy for high-risk prostate cancer. Urology, 59: 732-739, 2002.
8. Valicenti RK, Gomella LG, Perez CA: Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol, 13: 130-140, 2003.
9. Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA: Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Int J Radiat Oncol Biol Phys, 61: 714-724, 2005.
10. Vicini FA, Ziaja EL, Kestin LL, Brabbins DS, Stromberg JS, Gonzalez JA, Martinez AA: Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology, 54: 111-117, 1999.
11. Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM: Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol, 19: 1030-1039, 2001.
12. Nudell DM, Grossfeld GD, Weinberg VK, Roach M, III, Carroll PR: Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. Urology, 54: 1049-1057, 1999.
13. Parker C, Warde P, Catton C: Salvage radiotherapy for PSA failure after radical prostatectomy. Radiother Oncol, 61: 107-116, 2001.
14. Schild SE: Radiation therapy after prostatectomy: now or later? Semin Radiat Oncol, 8: 132-139, 1998.
15. Schild SE: Radiation therapy (RT) after prostatectomy: The case for salvage therapy as opposed to adjuvant therapy. Int J Cancer, 96:94-98, 2001.
16. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC: Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol, 159: 173-177, 1998.
17. Djavan B, Moul JW, Zlotta A, Remzi M, Ravery V: PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium. Eur Urol, 43: 12-27, 2003.
18. Egawa S, Matsumoto K, Suyama K, Soh S, Kuwao S, Iwamura M: Limited suppression of PSA after salvage radiotherapy for its isolated elevation after radical prostatectomy. Urology, 53: 148-154, 1999.
19. Haab F, Meulemans A, Boccon-Gibod L, Dauge MC, Delmas V, Hennequin C, Benbunan D, Boccon-Gibod L: Effect of radiation therapy after radical prostatectomy on serum prostate-specific antigen measured by an ultrasensitive assay. Urology, 45: 1022-1027, 1995.
20. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A: Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys, 56: 755-763, 2003.
21. Valicenti RK, Gomella LG: Durable efficacy of adjuvant radiation therapy for prostate cancer: will the benefit last? Semin Urol Oncol, 18: 115-120, 2000.
22. Anscher MS: Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate-specific antigen. Int J Cancer, 96: 91-93, 2001.
23. Anscher MS, Prosnitz LR: Multivariate analysis of factors predicting local relapse after radical prostatectomy - possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys, 21: 941-947, 1991.
24. Johnson CW, Anastasiadis AG, McKiernan JM, Salomon L, Eaton S, Goluboff ET, Olsson CA, Benson MC: Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles. Urol Oncol, 22: 107-111, 2004.
25. Anscher MS, Prosnitz LR: Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol, 138: 1407-1412, 1987.
26. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK: Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology, 64: 84-89, 2004.
27. Valicenti RK, Gomella LG, Ismail M, Strup SE, Mulholland SG, Dicker AP, Petersen RO, Newschaffer CJ: The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys, 45: 53-58, 1999.
28. Catalona WJ, Smith DS: 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol, 152: 1837-1842, 1994.
29. D'amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A: A multivariate analysis of clinical and pathological factors that predict for prostate-specific antigen failure after radical prostatectomy for prostate cancer. J Urol, 154: 131-138, 1995.
30. Masterson TA, Pettus JA, Middleton RG, Stephenson RA: Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status. Urology, 66: 152-155, 2005.
31. Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC: Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Urology, 62: 304-309, 2003.
32. Tefilli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon DJ, Pontes JE, Wood DP, Jr.: Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol, 160: 802-806, 1998.
33. Trapasso JG, deKernion JB, Smith RB, Dorey F: The incidence and significance of detectable levels of serum prostate-specific antigen after radical prostatectomy. J Urol, 152: 1821-1825, 1994.
34. Valicenti RK, Gomella LG, Ismail M, Mullholland SG, Petersen RO, Corn BW: Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control. Cancer, 82: 1909-1914, 1998.
35. Bloom KD, Richie JP, Schultz D, Renshaw A, Saegaert T, D'amico AV: Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Urology, 63: 333-336, 2004.
36. Kamat AM, Babaian K, Cheung MR, Naya Y, Huang SH, Kuban D, Babaian RJ: Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy. J Urol, 170: 1860-1863, 2003.
37. Leibovich BC, Engen DE, Patterson DE, Pisansky TM, Alexander EE, Blute ML, Bergstralh EJ, Zincke H: Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol, 163: 1178-1182, 2000.
38. Wu JJ, King SC, Montana GS, McKinstry CA, Anscher MS: The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys, 32: 317-323, 1995.
39. Coetzee LJ, Hars V, Paulson DF: Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology, 47: 232-235, 1996.
40. Schafer U, Witt F, Micke O, Willich N: Adjuvant radiotherapy in locally confined prostate cancer. Anticancer Res, 23: 983-985, 2003.
41. Crane CH, Rich TA, Read PW, Sanfilippo NJ, Gillenwater JY, Kelly MD: Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys, 39: 681-686, 1997.
42. Schild SE, Wong WW, Grado GL, Halyard MY, Novicki DE, Swanson SK, Larson TR, Ferrigni RG: The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys, 34: 535-541, 1996.
43. Zietman AL, Coen JJ, Shipley WU, Althausen AF: Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure. Urology, 42: 292-298, 1993.
44. Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, Milosevic M: Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol, 59: 51-60, 2001.
45. Morris MM, Dallow KC, Zietman AL, Park J, Althausen A, Heney NM, Shipley WU: Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys, 38: 731-736, 1997.
46. Corn BW, Winter K, Pilepich MV: Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. Urology, 54: 495-502, 1999.
47. Eulau SM, Tate DJ, Stamey TA, Bagshaw MA, Hancock SL: Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys, 41: 735-740, 1998.
48. Petrovich Z, Lieskovsky G, Langholz B, Luxton G, Jozsef G, Skinner DG: Radiotherapy following radical prostatectomy in patients with adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys, 21: 949-954, 1991.
49. Petrovich Z, Lieskovsky G, Langholz B, Jozsef G, Streeter OE, Jr., Skinner DG: Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys, 53: 600-609, 2002.